The Discounted Cash Flow (DCF) valuation of Abbott Laboratories (ABT) is 143.34 USD. With the latest stock price at 133.36 USD, the upside of Abbott Laboratories based on DCF is 7.5%.
Based on the latest price of 133.36 USD and our DCF valuation, Abbott Laboratories (ABT) is a buy. buying Abbott stocks now will result in a potential gain of 7.5%.
| Range | Selected | |
| WACC / Discount Rate | 6.2% - 8.8% | 7.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 88.48 - 397.69 | 143.34 |
| Upside | -33.7% - 198.2% | 7.5% |